Finally, a further surface reaction against Netrin-1 receptor has recently been described in patients with thymoma affected by Morvan syndrome or neuromyotonia and myasthenia gravis; the clinical relevance of this reactivity, which can be found together with CASPR2, needs further specification (48, 49). The gene discussed is CNTNAP2; the disease is thymoma.